Frequently Asked Questions > Research Collaborations > Access to Biospecimens
Access to Biospecimens
Can I buy specimens from Mayo Clinic?
Mayo Clinic does not sell biospecimens. However, we share samples for collaborative research projects.
Each scientific collaboration requires the following:
- A project-specific budget
- A collaboration agreement between BioPharma Diagnostics and the end user of the samples
- Approvals from the Mayo Clinic Institutional Review Board (IRB) and related committees
How can I obtain a budget estimate for my project?
Before a budget can be created, Mayo Clinic must determine the feasibility and scientific interest of the project.
To get started, you will need to provide the following information:
- A brief project summary detailing the intended use of samples and the scientific objectives, or the protocol if available
- Specimen requirements:
- Number of samples
- Sample type
- Minimum volume
- Stability requirements
- Timeline for obtaining samples
- Data needed to accompany samples
- Whether samples will be used for an FDA submission
- Budget goal (if known)
Can a Materials Transfer Agreement (MTA) be used for my project?
BioPharma Diagnostics does not use a Materials Transfer Agreement (MTA), because our agreements encompass more than specimen transfer, for example:
- Provision of associated data
- Lab analysis
- Contractual terms related to:
- Publication - Negotiable for each project
- Payment - To ensure that BioPharma Diagnostics' costs are covered based on project scope
- Intellectual property (IP)
- Ownership - Per institutional policy, BioPharma Diagnostics must retain ownership of all samples shared externally
- Option to license
Note: IP terms related to ownership and option to license must be included in all BioPharma Diagnostics collaboration agreements.